According to gene dysregulation analysis, the regulatory intensity of RUNX3→GPR15 is decreased from normal to cancer (Figure 2A), which suggests that RUNX3 at least partly contributes to the high expression of GPR15 in normal. The gene discussed is RUNX3; the disease is cancer.